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Summary 
Since monocytes and macrophages that arise during the culture of bone marrow progenitor cells 
are potential sources of interleukin 6 (Ib6), we investigated whether auto- or paracrine production 
of this factor is involved in colony formation by normal hematopoietic progenitor cells. We added 
a polyclonal anti-Ib6 antiserum and a monoclonal anti-Ib6 antibody to cultures of monocyte- 
and T  cell-depleted bone marrow cells.  Colony formation was stimulated with granulocyte/ 
monocyte-colony-stimulating factor (GM-CSF), monocyte-CSF, or II.-3. Addition of anti-IL-6 
antibody resulted in decreased numbers of monocytic colonies to 40-50% of control values, whereas 
the numbers of granulocytic colonies were not altered. The inhibitory effect was preserved in 
cultures of CD34 +-enriched bone marrow cells. As a second approach, we added a monoclonal 
antibody directed against the Ib6 receptor to cultures of monocyte- and T  cell-depleted bone 
marrow cells. This antibody almost completely inhibited the growth of monocytic colonies, again 
without  decreasing the number of granulocytic colonies.  Finally,  the importance of IL-6 in 
monocytopoiesis was demonstrated in serum-deprived bone marrow cultures: addition of exogenous 
IL-6 to cultures stimulated with GM-CSF resulted in increased numbers of monocytic colonies. 
Our results indicate that the permissive presence of IL-6 is required for optimal monocytic colony 
formation by bone marrow progenitor cells. 
I 
b6 is involved in the development of B and T  lympho- 
, cytes and is one of the major cytokines that induce the 
acute phase response upon infection or injury (1). In addi- 
tion, IL-6 has been attributed a role in myelopoiesis. Alone, 
IL-6 does not induce colony formation by bone marrow pro- 
genitor cells, but it enhances Ib3-stimulated proliferation of 
myeloid progenitor cells (2) and the formation of monocytic 
colonies at suboptimal concentrations of monocyte (M)-CSF 
(3). Furthermore, it stimulates thrombocytopoiesis, both in 
vitro and in vivo (4,  5). 
Colony formation assays have proved to be invaluable in 
the study of factors that regulate hematopoiesis. To study 
possible direct effects of cytokines, suspensions of purified 
bone marrow progenitor cells may be used. However, auto- 
crine or paracrine production of cytokines by progenitor cells 
or their offspring may still influence colony formation. Since 
monocytic cells are potent producers of Ib6 (1, 6), and these 
cells originate in cultures of bone marrow progenitor cells, 
we investigated the role of auto- and paracrine production 
of IL-6 on the development of colonies using neutralizing 
antibodies against Ib6 and the Ib6R. Since monocytes rap- 
idly lose viability in serum-free conditions (7), we also tested 
whether addition of Ib6  resulted in enhanced monocytic 
colony formation in serum-deprived cultures. 
Materials and Methods 
Cytokines and Antibodies.  Human rlb6 was kindly provided by 
Dr. L. A. A,arden (CLB, Amsterdam, The Netherlands); human 
rGM-CSF was provided  by Sandoz Pharma BV (Uden, The Nether- 
lands); human rM-CSF was a gift from Dr. P. Ralph (Cetus Corp., 
Emeryville, CA; human rG-CSF was a gift from Dr. B. Altrock 
(Amgen, Thousand Oaks, CA); human rib3 was a gift from Dr. 
G. Wagemaker (Netherlands Organization  for Applied Scientific 
Research, Delft, The Netherlands). Mouse anti-human Ib6 mAb 
(neutralizing 10 U/ml II.-6 at a dilution of 1:10- s) and a polyclonal 
rabbit anti-human IL-6 (neutralizing 10 U/ml II.,6 at a dilution 
of 3:10  -4) were raised against purified rib6. Anti-IL-6R antibody, 
PM-1 (8), was kindly provided by Dr. T. Kishimoto (Osaka Univer- 
sity, Japan). This antibody competes with Ib6 for binding to the 
Ib6R (10 #g/ml neutralizes the activity of 2 ng/ml IL-6). 
Cell Pre~rations.  Bone marrow was obtained after informed 
consent from donors for allogeneic bone marrow transplantation 
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tomy. Light density cells were isohted by FicoLl  separation (1,000 g, 
20 rain,  d  =  1.077 g/cm3). Interphase  cells were depleted of 
monocytes by carbonyl iron phagocytosis (9), and T cells were re- 
moved by rosetting with sheep erythrocytes and Ficoll separation 
(10), yidding cell suspensions with <1% monocytes (staining with 
c~-naphthyl acetate esterase [ANAE]) and <1% T cells (staining 
with anti-CD3  [Becton Dickinson & Co., Mountain View, CA] 
and FITC-conjugated goat anti-mouse serum [GAM-FITC; Cen- 
tral Laboratory of the Red Cross Blood Transfusion Service, Am- 
sterdam, The Netherlands]).  From  these suspensions, CD34+/ 
HLA-DR + cells were isolated by FACS  ® (Becton Dickinson  & 
Co.). Cells were preincubated with 5% (vol/vol) rabbit serum (30 
rain at 37°C) to prevent nonspecific Fc binding and stained with 
anti-HLA-DR (Becton Dickinson & Co.) and GAM-FITC (CLB). 
After incubation  with routine  serum (50%;  vol/vol),  blocking 
nonspecific binding  of antibodies to the GAM-FITC, cells were 
stained with PE-conjugated anti-CD34 (MY10; Becton Dickinson 
& Co.). 
Bone Marrow Cultures.  Monocyte- and T  cell-depleted bone 
marrow  cells (0.3  or  0.5  x  10S/ml) or  CD34+/HLA-DR +- 
enriched bone marrow cells (l(Y/ml) were cultured in IMDM con- 
taining 20% FCS (Sanbio, Uden, The Netherlands), 5  x  10 -s M 
2-ME (Sigma Chemical Co., St. Louis, MO), 0.5 g/liter deionized 
BSA, 0.47 g/liter human transferrin (Behringwerke, Hoechst, Am- 
sterdam,  The  Netherlands),  10 -s  M  FeCIj.6H20,  and  0.98% 
methylcellulose. In serum-deprived cultures, the FCS was replaced 
by 2  x  10 -4 M cholesterol (Sigma Chemical Co.) and 10 #g/ml 
insulin (Sigma Chemical Co.) as described (11). Colony formation 
was induced with G-CSF (10 ng/ml), M-CSF (1,000 U/ml), Ib3 
(50 ng/ml), or GM-CSF (50 U/ml). Six replicates of 100/zl were 
plated in flat-bottomed microtiter plates (Greiner, Alphen a/d Rijn, 
The  Netherlands),  except for experiments  with  CD34 ÷ cells, 
where two replicates of I  ml were plated in 25-mm petri dishes 
(Greiner). Cultures were kept at 37°C in a fully humidified, 5% 
COs atmosphere. CFU-G (>50 granulocytes) and CFU-M (>20 
macrophages) were scored on day 14. Colonies were mass harvested 
or picked individually  with a micropipette, and stained with ANAl/ 
or May-Griinwald Giemsa. 
Results 
Effect  of Anti-IL6  Antibody  on Monocytic  Colony  Forma- 
tion.  We investigated the role of endogenously produced I1.6 
in serum-containing cultures of  monocyte- and T cell-depleted 
bone marrow cells. Increasing concentrations of an anti-I1,6 
mAb were added to cultures that were stimulated with GM- 
CSF (Fig.  1). A dose-dependent reduction of the number of 
monocytic colonies to 40% of control values was observed, 
with the number of granttlocytic colonies unaffected. A similar 
effect was observed when a polyclonal anti-I1,6 antiserum 
was used. In the presence of this antiserum, CFU-G growth 
was 110 ±  27% and CFU-M growth was 50 ±  11% of  con- 
trol growth (mean  ±  SD,  n  =  5). 
To test whether the specific inhibition of monocytic colony 
formation was dependent on the growth factor used to in- 
duce colony formation, we added anti-I1.6 mAb to cultures 
that were stimulated with G-CSF, M-CSF, or IL-3 (Fig.  2). 
In these studies, a similar inhibition of monocytic colony for- 
mation was observed, with the number of granulocytic colo- 
nies  again unaffected. 
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Figure 1.  Effect  ofanti-lb6 mAb on the formation  ofgranulocytic  and 
monocytic  colony  formation  by monocyte-  and T cell-depleted  bone  marrow 
cells. Data are expressed  as the percentage  of colony  formation  in control 
cultures without antibody added (mean _+  SD, n =  5). Mean control 
growth was 110 _+  15 CFU-G and 87 +_  16 CFU-M/0.5 x  103 cells. 
Inhibition of monocytic colony formation was not due to 
nonspecific toxicity of the antibody, since  the numbers of 
granulocytic colonies were not affected, and the effect could 
be reversed by the addition of excess concentrations of exog- 
enous I1,6 (200 ng/ml) (Fig.  2).  Dose-dependent suppres- 
sion of monocytic colony formation was preserved to the same 
degree in cultures of CD34 + bone marrow cells stimulated 
with GM-CSF (50 U/ml). Anti-Ib6 mAb at a dilution of 
1:10  s to 1:200 suppressed CFU-M growth to 56  ±  5% (n 
=  5, duplicate cultures) of  control values, whereas the number 
of  granulocytic colonies was not affected. Mean control growth 
was  17 CFU-G and 36 CFU-M/IO  3 cells. 
Effect of Anti-IL.6R  Antibody on Monocytic Colony Forma- 
tion.  To further substantiate the role of II.6 in monocytic 
colony formation, we tested whether blocking of the I1.6R 
by an anti-IL-6R antibody was able to inhibit monocytic colony 
formation. Almost complete inhibition (to 2% of control 
values, n  =  4) of monocytic colony formation was observed 
in cultures containing the anti-I1.6R antibody. The number 
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Figure 2.  Effect  of anti-ll.,6 antibody  (1:103) on granulocytic  and mono- 
cytic colony  formation  by monocyte-  and T cell-depleted  bone marrow 
cells stimulated with G-CSF (10 ng/ml), M-CSF (1,000 U/ml), lb3 (50 
ng/ml), or GM-CSF (50 U/ml). Data are expressed  as the percentage  of 
colony formation in control cuhures without anti-Ib6 antibody (mean 
-+  SD, n =  5). 
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Effect of anti-IL-6R antibody (10/~g/ml) on granulocytic and  Figure 3. 
monocytic colony formation by monocyte- and T cell-depleted  bone marrow 
cells stimulated with GM-CSF (50 U/ml). Mean values of four experi- 
ments  _+  SD are given. 
of granulocytic colonies was unaffected (Figs. 3 and 4), indi- 
cating that the effect was not due to toxicity of the antibody. 
Additionally, specificity could be confirmed since this anti- 
body competes with IL-6 for binding to the Ib6R (8). In 
two cases tested, inhibition of monocytic colony formation 
to 2% and 3% of control values was reversed to 112% and 
Table  1.  Effect of Interleukin  6  on Monocytic Colony  Formation 
in Serum-deprived  Cultures of Monocyte- and T  Cell-depleted Bone 
Marrow Cells 
Stimulus 
Colonies/5  x  104 
bone marrow cells 
Exp.  1  Exp.  2 
CFU-G CFU-M CFU-G CFU-M 
Culture medium  0  0  0  0 
GM-CSF (50 U/ml)  27  23  77  3 
GM-CSF (500 U/ml)  29  21  94  3 
GM-CSF (50 U/ml) + IL-6 
(200 ng/ml)  28  66  84  24 
GM-CSF (500 U/ml) + IL-6 
(200 ng/ml)  30  77  85  24 
51% of  control values by the addition of exogenous IL-6 (200 
ng/ml). 
Effect of  lI.,6 on Monocytic Colony Formation in Serum-deprived 
Cultures.  Since  monocytes rapidly lose viability in sernm- 
free conditions, and serum may contain IL-6 or IL-6-inducing 
factors, we tested whether IL-6 was able to enhance mono- 
cytic colony formation in serum-deprived cultures of mono- 
cyte- and T cell-depleted bone marrow cells. In the presence 
of  GM-CSF (50-500 U/ml), low numbers of  monocytic  colo- 
nies were obtained.  In two experiments,  addition of IL-6 
resulted in a four- and eightfold increase in the number of 
monocytic colonies (Table 1). The number of granulocytic 
colonies was not affected. 
Figure 4.  Photomicrograph  of cell preparations prepared from cultures 
of monocyte- and T call--depleted bone marrow  cells cultured with (-4) 
GM-CSF (50 U/ml) or (B) GM-CSF (50 U/ml)  +  anti-lb6K antibody 
(1:103). After  14 d of culture,  cells were mass harvested and monocytic 
cells were stained with ANAE as described,  x630. 
Discussion 
In this report we show by three different approaches that 
IL-6 plays an important role in monocyfic colony formation 
by bone marrow progenitor cells. Inhibition of monocytic 
colony formation by anti-IL-6R  antibody was much more 
pronounced (98% inhibition) than inhibition by anti-Ib6 an- 
tibodies (50-60% inhibition).  This difference might be ex- 
plained by the existence of high and low affinity types of 
receptor-ligand binding between IL-6 and its receptor (12), 
the anti-IL-6 antibodies being able to compete only with the 
low affinity binding. Alternatively,  the IL-6R may bind to 
more than one ligand,  being the anti-Ib6R antibody able 
to block binding of both ligands. 
These data underscore that in standard bone marrow cul- 
tures, on which the concept of regulation of hematopoiesis 
largely has been based, intermediate production of cytokines 
by the progenitor cells or their offspring may play an impor- 
tant role. 
Several hypotheses may explain our data. IL-6 may act as 
a competence factor, inducing sensitivity of progenitor cells 
to growth factors, or as a progression factor, enabling cells 
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ternatively,  I1:6  may  enhance  progenitor  cell  survival  by 
preventing apoptosis (programmed cell death). Recently, sev- 
eral authors suggested that hematopoietic growth factors pre- 
vent apoptosis in hematopoietic progenitor cells (13-15).  Cells 
from I1:3, GMoCSF-, and G-CSF-dependent murine cell lines, 
died by apoptosis upon withdrawal of the relevant growth 
factor. Remarkably, I1:6 inhibited apoptosis that was induced 
by the expression of the putative tumor-suppressor protein 
p53 in a murine myeloid leukemia cell line (19). Serum star- 
vation of human  peripheral  blood monocytes causes  apop- 
toffs, which can be prevented by the addition of I1:1~8, TNF-c~, 
or LPS (7). Although Ib6 did not prevent apoptosis in these 
experiments, prevention of apoptosis by Ib6 in more imma- 
ture monocytic precursors cells, as studied in our experiments, 
remains possible. 
If Ib6 has a similar permissive role in monocytopoiesis in 
vivo, this would add another level of control over the produc- 
tion of monocytes and macrophages.  The high concentra- 
tion of I1:6 in inflammatory tissues and the high titer in plasma 
upon infection and injury may be of relevance in this respect. 
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